Revelation Biosciences Inc. (REVB)
NASDAQ: REVBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 10:41 AM ET
REVB stock chart
Technical analysisKey statistics
All statistics- Market cap
- $3.23M
- P/E (TTM)
- 0.18
- EPS (TTM)
- $4.60
- Dividend yield
- None
- 52-week range
- 0.75 – 6.24
- Day range
- 0.787 – 0.81
- Volume / Avg
- 28.22K / 39.03K
- Beta
- —
- Shares outstanding
- 3.98M
- Next earnings
- Nov 5, 2026
52-week range
REVB stock today
Shares of Revelation Biosciences (REVB) are trading lower on Oct 8 at $0.81, a drop of 2.19% or $0.0181 per share, versus the S&P 500's 0.36% decline. Shares are 87.0% below their 52-week high of $6.24 and 8.0% above the 52-week low of $0.75, near the bottom of the past year's range. Revelation Biosciences trades at 0.2x its trailing twelve-month earnings per share of $4.60.
Revelation Biosciences's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Revelation Biosciences
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- IPO year
- 2020
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.88
Revelation Biosciences peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ONCOOnconetix Inc. | 0.6277 | +5.11% | $3.29M | vs REVB |
| MBIOMustang Bio Inc. | 0.4382 | -2.67% | $3.32M | vs REVB |
| APVOAptevo Therapeutics Inc. | 1.84 | 0.00% | $3.33M | vs REVB |
| KAPAKairos Pharma Ltd. | 0.9625 | +10.72% | $3.26M | vs REVB |
| CVKDCadrenal Therapeutics Inc. | 0.91 | -6.41% | $3.25M | vs REVB |
| CMNDClearmind Medicine Inc. | 6.65 | +0.68% | $3.37M | vs REVB |
| HCWBHCW Biologics Inc. | 1.52 | -2.56% | $3.40M | vs REVB |
| XRTXXORTX Therapeutics Inc. | 1.75 | +0.29% | $3.18M | vs REVB |
Indexes, lists and sector
Revelation Biosciences stock FAQ
What is Revelation Biosciences's stock price today?
REVB last traded at $0.81 as of Oct 8, 10:41 AM EDT, down 2.19% on the day. Prices are delayed at least 15 minutes.
When is Revelation Biosciences's next earnings date?
Revelation Biosciences is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.88.
What is REVB's P/E ratio?
REVB trades at a trailing P/E ratio of 0.18.
What is the REVB 52-week high?
The 52-week high for REVB is $6.24 and the 52-week low is $0.75. The stock is currently 87.0% below its high.